Lung cancer

Metastatic NSCLC an ideal benchmark for end-of-life-care

People with metastatic NSCLC have a poor prognosis, making the disease an ideal benchmark to measure the quality of end-of-life care, palliative care experts say. The overview of care for over 6,000 patients with metastatic NSCLC in Victoria found that patients did not generally receive aggressive care — intensive care treatment or chemotherapy — in ...

Already a member?

Login to keep reading.

© 2021 the limbic